Acropolis Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
AP
CA
Acropolis Investment Management's GILD Position: Q3 2026 in Review
Acropolis Investment Management increased its Gilead Sciences (GILD) stake by 46% in Q3 2026, buying an estimated $103K and bringing the position to 2,337 shares worth $348K. The position accounts for 0.01% of the portfolio, ranked #221.
Acropolis Investment Management first reported a position in GILD in Q3 2015 and has held it in 16 quarters since. The position peaked at $1.23M in Q1 2016. 296 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Acropolis Investment Management held 2,337 shares of Gilead Sciences worth $348K as of Q3 2026.
- Acropolis Investment Management bought 731 Gilead Sciences shares in Q3 2026, an estimated $103K.
- Gilead Sciences made up 0.01% of Acropolis Investment Management's portfolio in Q3 2026, its #221 holding.
- Acropolis Investment Management first reported a position in Gilead Sciences in Q3 2015 and has held it in 16 quarters since.
- Acropolis Investment Management's Gilead Sciences position peaked at $1.23M in Q1 2016.
- 296 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Acropolis Investment Management's 13F filing for Q3 2026, filed 8 Oct 2026.